HeartBeam, Inc.
BEAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001779372
No open-market purchases or sales by HeartBeam, Inc. insiders were filed in the last 90 days; 41 institutions reported holding it in 13F filings for Q2 2026, worth $6.08M in total; no superinvestor holds it.
Other share classesBEATW
Q2 2025 vs. Q1 2025
How the institutions holding HeartBeam, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 35 | 40 | +5 |
| Shares | 3.04M | 3.60M | +557.4K (+18.3%) |
| Value | $6.11M | $4.50M | −$1.61M (−26.4%) |
New holders (7)
Institutions that held HeartBeam, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 29,632 | $37.0K | 0.00% |
| Virtu Financial LLC | 27,345 | $34.0K | 0.00% |
| Squarepoint Ops LLC | 23,798 | $29.7K | 0.00% |
| Goldman Sachs Group Inc | 22,999 | $28.7K | 0.00% |
| HRT Financial LP | 20,851 | $26.0K | 0.00% |
| Merit Financial Group, LLC | 15,274 | $19.1K | 0.00% |
| Ronald Blue Trust, Inc. | 1,928 | $2.41K | 0.00% |
Sold out (2)
Institutions that held HeartBeam, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Cetera Investment Advisers | 10,400 | $20.9K |
| JPMorgan Chase & Co | 44 | $88 |